Table 2.
Clinical parameters by study group before and after treatment.
| Hypertension (H) | Hypertensive prediabetes (HD) | |||
|---|---|---|---|---|
| Baseline | 12 weeks | Baseline | 12 weeks | |
| SBP, mmHg | 147.00 ± 5.67 | 136.77 ± 6.91# | 149.74 ± 6.77 | 137.17 ± 4.84⋇ |
| DBP, mmHg | 92.86 ± 5.86 | 84.50 ± 5.91# | 95.30 ± 8.00 | 84.70 ± 4.64⋇ |
| Glu, mmol/L | 5.27 ± 0.25 | 5.25 ± 0.36 | 6.03 ± 0.44 | 6.13 ± 0.54 |
| 2 h-Glu, mmol/L | 6.10 ± 0.90 | NA | 8.04 ± 1.43 | NA |
| HbA1c, (%) | 5.48 ± 0.26 | 5.45 ± 0.25 | 5.90 ± 0.33 | 5.94 ± 0.30 |
| Tc, mmol/L | 5.67 ± 0.41 | 3.98 ± 0.80# | 5.60 ± 0.70 | 3.94 ± 0.88⋇ |
| LDL-c, mmol/L | 3.45 ± 0.32 | 2.07 ± 0.65# | 3.30 ± 0.52 | 1.95 ± 0.54⋇ |
| ALT, U/L | 28.50 ± 12.37 | 32.95 ± 15.55 | 28.70 ± 15.18 | 39.0 ± 27.50 |
| Cr, μmol/L | 63.18 ± 13.95 | 62.95 ± 14.66 | 69.48 ± 11.05 | 67.43 ± 13.67 |
Data are presented as mean ± SD. #P < 0.01, compared with baseline H. ⋇P < 0.01, compared with baseline HD. NA, not applicable.